This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukui, N.
Right arrow Articles by Sandell, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukui, N.
Right arrow Articles by Sandell, L. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Facebook   Add to Technorati   Add to Twitter  
What's this?
The Journal of Bone and Joint Surgery (American) 85:59-66 (2003)
© 2003 The Journal of Bone and Joint Surgery, Inc.


Basic Science

Stimulation of BMP-2 Expression by Pro-Inflammatory Cytokines IL-1 and TNF-{alpha} in Normal and Osteoarthritic Chondrocytes

Naoshi Fukui, MD, Yong Zhu, MD, William J. Maloney, MD, John Clohisy, MD and Linda J. Sandell, PhD

Abstract

Background: Destruction of cartilage in osteoarthritis is a direct effect of an imbalance between catabolic and anabolic activities in the tissue. While a great deal is known about catabolism, we sought to determine the biochemical basis of the anabolic activity.

Methods: Cartilage was isolated from normal and osteoarthritic patients and subjected to both cell and explant culture. mRNA expression levels of the growth and differentiation factors bone morphogenetic protein-2 (BMP-2), BMP-4, BMP-6, cartilage-derived morphogenetic protein-1 (CDMP-1), connective tissue growth factor (CTGF), and activin were determined. BMP-2 was localized in osteoarthritic cartilage by immunohistochemistry. To determine the mechanism of BMP-2 stimulation, chondrocytes were cultured with TGF-ß (transforming growth factor-ß), insulin-like growth factor-1 (IGF-1), interleukin-1ß (IL-1ß), and tumor necrosis factor-{alpha} (TNF-{alpha}). The BMP-2 response was monitored by quantitative real-time polymerase chain reaction to ascertain mRNA levels and by Western blot analysis, BMP-2 protein quantitation, and immunohistochemistry to determine protein levels.

Results: BMP-2 was found to be up-regulated in osteoarthritic chondrocytes and cartilage. In cell culture, IL-1ß and TNF-{alpha} increased BMP-2 mRNA and protein levels by eightfold and fifteenfold, respectively, whereas IGF-1 and TGF-ß1 had no effect. In cartilage explant cultures, IL-1ß and TNF-{alpha} increased BMP-2 levels both intracellularly and extracellularly. Functional relevance was suggested by co-localization of BMP-2 and newly synthesized type-II procollagen within the same cells.

Conclusions: BMP-2 acts as a stimulus of anabolic activities in normal and osteoarthritic chondrocytes. Furthermore, the pro-inflammatory cytokines IL-1ß and TNF-{alpha}, known to be present in synovium and cartilage of patients with osteoarthritis, stimulate the production of active BMP-2.

Clinical Relevance: These results suggest that, in addition to their role in catabolism of cartilage in osteoarthritis, the pro-inflammatory cytokines IL-1ß and TNF-{alpha} may stimulate anabolic events through production of BMP-2. BMP-2, in turn, increases the synthesis of chondrocyte extracellular molecules, aggrecan and type-II collagen. Consequently, local inflammatory events may contribute to the remodeling or repair of cartilage.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Facebook Facebook   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JDRHome page
W.H. Lim, J. Toothman, J.H. Miller, R.H. Tallents, S.M. Brouxhon, M.E. Olschowka, and S. Kyrkanides
IL-1{beta} Inhibits TGF{beta} in the Temporomandibular Joint
Journal of Dental Research, June 1, 2009; 88(6): 557 - 562.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M B Goldring, M Otero, K Tsuchimochi, K Ijiri, and Y Li
Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism
Ann Rheum Dis, December 1, 2008; 67(Suppl_3): iii75 - iii82.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. H. Kariyawasam, G. Xanthou, J. Barkans, M. Aizen, A. B. Kay, and D. S. Robinson
Basal Expression of Bone Morphogenetic Protein Receptor Is Reduced in Mild Asthma
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1074 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
E N Blaney Davidson, E L Vitters, P M van der Kraan, and W B van den Berg
Expression of transforming growth factor-{beta} (TGF{beta}) and the TGF{beta} signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation
Ann Rheum Dis, November 1, 2006; 65(11): 1414 - 1421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Fukui, Y. Ikeda, T. Ohnuki, A. Hikita, S. Tanaka, S. Yamane, R. Suzuki, L. J. Sandell, and T. Ochi
Pro-inflammatory Cytokine Tumor Necrosis Factor-{alpha} Induces Bone Morphogenetic Protein-2 in Chondrocytes via mRNA Stabilization and Transcriptional Up-regulation
J. Biol. Chem., September 15, 2006; 281(37): 27229 - 27241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Takahashi, N. Goto, Y. Kojima, Y. Tsuda, Y. Morio, M. Muramatsu, and Y. Fukuchi
Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L450 - L458.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G Tardif, J-P Pelletier, D Hum, C Boileau, N Duval, and J Martel-Pelletier
Differential regulation of the bone morphogenic protein antagonist chordin in human normal and osteoarthritic chondrocytes
Ann Rheum Dis, February 1, 2006; 65(2): 261 - 264.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. A. Hruska, S. Mathew, and G. Saab
Bone Morphogenetic Proteins in Vascular Calcification
Circ. Res., July 22, 2005; 97(2): 105 - 114.
[Abstract] [Full Text] [PDF]